Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis

Oncology Reports

Volumn 21, Issue 6, 2009, Pages 1391-1396

  Kim, Kiyoon ^a   Yu, Miran ^a   Han, Seulhee ^a   Oh, Inkyung ^a   Choi, Young Jun ^a   Kim, Sungsoo ^a   Yoon, Kyungsik ^a   Jung, Minhyung ^a   Choe, Wonchae ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Cervical cancer; Peroxireoxin; Reactive oxidative species

Indexed keywords

PEROXIREDOXIN; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PEROXIREDOXIN 3; PEROXIREDOXIN 4; UNCLASSIFIED DRUG; ISOENZYME; PRDX1 PROTEIN, HUMAN; PRDX2 PROTEIN, HUMAN; PRDX3 PROTEIN, HUMAN; PRDX4 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; CANCER STAGING; ENZYMOLOGY; PATHOLOGY; TISSUE MICROARRAY; UTERINE CERVIX TUMOR;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; ISOENZYMES; NEOPLASM STAGING; PEROXIREDOXINS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 67649972184     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000366     Document Type: Article

References (26)

1. Notani PN: Global variation in cancer incidence and mortality. Curr Sci 81: 465-474, 2001.
2. Kim K, Kim IH, Lee KY, et al: Stadtman: the isolation and purification of a specific 'protector' protein which inhibits enzyme inactivation by a thiol/Fe(III)/O2 mixed-function oxidation system. J Biol Chem 263: 4704-4711, 1988.
3. Chae HZ, Kim IH, Kim K, et al: Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. J Biol Chem 268: 16815-16821, 1993.
4. Naidu MK, Suryakar AN, Swami SC, et al: Oxidative stress and antioxidant status in cervical cancer patients. IJCB 22: 140-144, 2007.
5. Butterfield LH, Merino A, Golub SH, et al: From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins. Antioxid Redox Signal 1: 385-402, 1999.
6. Lehtonen ST, Svensk AM, Soini Y, et al: Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer 111: 514-521, 2004.
7. Chang JW, Lee SH, Jeong JY, et al: Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer. FEBS Lett 579: 2873-2877, 2005.
8. Karihtala P, Mäntyniemi A, Kang SW, et al: Peroxiredoxins in breast carcinoma. Clin Cancer Res 9: 3418-3424, 2003.
9. Park JH, Kim YS, Lee HL, et al: Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. Respirology 11: 269-275, 2006.
10. Kim YJ, Ahn JY, Liang P, et al: Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology. Cancer Res 67: 546-555, 2007.
11. Yanagawa T, Iwasa S, Ishii T, et al: Peroxiredoxin I expression in oral cancer: a potential new tumor marker. Cancer Lett 156: 27-35, 2000.
12. Yanagawa T, Ishikawa T, Ishii T, et al: Peroxiredoxin I expression in human thyroid tumors. Cancer Lett 145: 127-132, 1999.
13. Chang JW, Jeon HB, Lee JH, et al: Augmented expression of peroxiredoxin I in lung cancer. Biochem Biophys Res Commun 289: 507-512, 2001.
14. Conway JP and Kinter M: Dual role of peroxiredoxin I in macrophage-derived foam cells. J Biol Chem 281: 27991-28001, 2006.
15. Lee SC, Na YP, Lee JB, et al: Expression of peroxiredoxin II in vascular tumors of the skin: a novel vascular marker of endothelial cells. J Am Acad Dermatol 49: 487-491, 2003.
16. Choi JH, Kim TN, Kim S, et al: Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res 22: 3331-3335, 2002.
17. Seo MS, Kang SW, Kim K, et al: Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem 275: 20346-20354, 2000.
18. Hofmann B, Hecht HJ and Flohé: Peroxiredoxin. Biol Chem 383: 347-364, 2002.
19. Immenschuh S and Baumgart-Vogt E: Peroxiredoxins, oxidative stress and cell proliferation. Antioxid Redox Signal 7: 768-777, 205.
20. Banmeyer I, Marchand C, Clippe A, et al: Human mitochondrial peroxiredoxin 5 protects from mitochondrial DNA damages induced by hydrogen peroxide. FEBS Lett 579: 2327-2333, 2005.
21. Noh DY, Ahn SJ, Lee RA, et al: Overexpression of peroxiredoxin in human breast cancer. Anticancer Res 21: 2085-2090, 2001.
22. Yanagawa T, Ishikawa T, Ishii T, et al: Peroxiredoxin I expression in human tyroid tumors. Cancer Lett 145: 127-132, 1999.
23. Neumann CA, Krause DS, Carman CV, et al: Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424: 561-565, 2003.
24. Kinnula VL, Lehtonen S, Kaarteenaho-Wiik R, et al: cell specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis. Thorax 57: 157-164, 2002.
25. Kim JH, Bogner PN, Ramnath N, et al: Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer. Clin Cancer Res 13: 3875-3882, 2007.
26. Kinnula VL, Lehtonen S, Sormunen R, et al: Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Pathol 196: 316-323, 2002.